Live from AUA2024: Highlights in Bladder Cancer

CME Available: https://auau.auanet.org/node/41085

At the conclusion of this activity, participants will be able to:

1. Discuss the newly released amendment to the AUA/SUO Guideline on Non-Muscle Invasive Bladder Cancer.

2. Describe recent developments in the management of non-muscle invasive bladder cancer.

3. Review current management approaches for non-metastatic muscle-invasive bladder cancer.

4. Identify novel therapies and their mechanism of action in the management of advanced bladder cancer.

ACKNOWLEDGEMENT

This educational activity is supported by independent educational grant from:

Merck & Co., Inc.